BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17325820)

  • 1. Paraneoplastic diseases associated with thymoma.
    Evoli A; Minicuci GM; Vitaliani R; Battaglia A; Della Marca G; Lauriola L; Fattorossi A
    J Neurol; 2007 Jun; 254(6):756-62. PubMed ID: 17325820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease.
    Hoffacker V; Schultz A; Tiesinga JJ; Gold R; Schalke B; Nix W; Kiefer R; Müller-Hermelink HK; Marx A
    Blood; 2000 Dec; 96(12):3872-9. PubMed ID: 11090072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormal T cell maturation in myasthenia gravis associated thymomas].
    Nenninger R; Schultz A; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():256-60. PubMed ID: 9065022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic autoimmunity in thymus tumors.
    Marx A; Schultz A; Wilisch A; Helmreich M; Nenninger R; Müller-Hermelink HK
    Dev Immunol; 1998; 6(1-2):129-40. PubMed ID: 9716914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathomechanisms of paraneoplastic myasthenia gravis.
    Ströbel P; Preisshofen T; Helmreich M; Müller-Hermelink HK; Marx A
    Clin Dev Immunol; 2003 Mar; 10(1):7-12. PubMed ID: 14575152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis.
    Buckley C; Douek D; Newsom-Davis J; Vincent A; Willcox N
    Ann Neurol; 2001 Jul; 50(1):64-72. PubMed ID: 11456312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in thymoma-associated myasthenia gravis with myositis or neuromyotonia.
    Mygland A; Vincent A; Newsom-Davis J; Kaminski H; Zorzato F; Agius M; Gilhus NE; Aarli JA
    Arch Neurol; 2000 Apr; 57(4):527-31. PubMed ID: 10768628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two-color flow cytometric analysis of thymic lymphocytes from patients with myasthenia gravis and/or thymoma.
    Ichikawa Y; Shimizu H; Yoshida M; Arimori S
    Clin Immunol Immunopathol; 1992 Jan; 62(1 Pt 1):91-6. PubMed ID: 1370261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraneoplastic myasthenia gravis correlates with generation of mature naive CD4(+) T cells in thymomas.
    Ströbel P; Helmreich M; Menioudakis G; Lewin SR; Rüdiger T; Bauer A; Hoffacker V; Gold R; Nix W; Schalke B; Elert O; Semik M; Müller-Hermelink HK; Marx A
    Blood; 2002 Jul; 100(1):159-66. PubMed ID: 12070022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal thymocyte development and generation of autoreactive T cells in mixed and cortical thymomas.
    Nenninger R; Schultz A; Hoffacker V; Helmreich M; Wilisch A; Vandekerckhove B; Hünig T; Schalke B; Schneider C; Tzartos S; Kalbacher H; Müller-Hermelink HK; Marx A
    Lab Invest; 1998 Jun; 78(6):743-53. PubMed ID: 9645765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of T-cells in the initiation of autoantibody responses in thymoma patients.
    Vincent A; Willcox N
    Pathol Res Pract; 1999; 195(8):535-40. PubMed ID: 10483583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocytes in thymoma: association with myasthenia gravis is correlated with increased number of single-positive cells.
    Fujii Y; Hayakawa M; Inada K; Nakahara K
    Eur J Immunol; 1990 Oct; 20(10):2355-8. PubMed ID: 2147007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thymopoiesis, regulatory T cells, and TCRVbeta expression in thymoma with and without myasthenia gravis, and modulatory effects of steroid therapy.
    Fattorossi A; Battaglia A; Buzzonetti A; Minicuci G; Riso R; Peri L; Scambia G; Evoli A
    J Clin Immunol; 2008 Mar; 28(2):194-206. PubMed ID: 18000743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type B thymomas in patients with myasthenia gravis display a distinctive pattern of αβ TCR and IL-7 receptor α expression on CD4
    Wang T; Wang B; Fan X; Cai Y; Li L; Fu S
    Autoimmunity; 2024 Apr; 57(1):2347379. PubMed ID: 38723105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of positive selection of thymoma-associated T cells in the pathogenesis of myasthenia gravis.
    Inada K; Okumura M; Shiono H; Inoue M; Kadota Y; Ohta M; Matsuda H
    J Surg Res; 2005 Jun; 126(1):34-40. PubMed ID: 15916972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell development in human thymoma.
    Inoue M; Fujii Y; Okumura M; Miyoshi S; Shiono H; Fukuhara K; Kadota Y; Matsuda H
    Pathol Res Pract; 1999; 195(8):541-7. PubMed ID: 10483584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered naive CD4
    Kohler S; Keil T; Alexander T; Thiel A; Swierzy M; Ismail M; Rückert JC; Meisel A
    J Neuroimmunol; 2019 Feb; 327():10-14. PubMed ID: 30686546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological function of thymoma and pathogenesis of paraneoplastic myasthenia gravis.
    Okumura M; Fujii Y; Shiono H; Inoue M; Minami M; Utsumi T; Kadota Y; Sawa Y
    Gen Thorac Cardiovasc Surg; 2008 Apr; 56(4):143-50. PubMed ID: 18401674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased frequency of intrathymic regulatory T cells in patients with myasthenia-associated thymoma.
    Luther C; Poeschel S; Varga M; Melms A; Tolosa E
    J Neuroimmunol; 2005 Jul; 164(1-2):124-8. PubMed ID: 15923045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mature CD4 single positive thymocytes in human Thymoma: T cells may differentiate in the thymic epithelial cell tumor.
    Inoue M; Fujii Y; Okumura M; Takeuchi Y; Shiono H; Miyoshi S; Matsuda H; Shirakura R
    Pathobiology; 1997; 65(4):216-22. PubMed ID: 9396046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.